Abstract

The injection of a large number of homologous lymphoid cells kills x- irradiated mice protected with isologous or homologous bone marrow within 1 to 2 weeks. The injection of a smaller number of homologous lymphoid cells kills the mice after a longer interval. Parental-strain lymphoid cells have a detrimental effect in irradiated F/sub 1/ hybrids, but F/sub 1/ hybrid lymph-node cells produce no ill effect in parental-strain mice. Rat lymph-node cells only have a lethal effect in irradiated mice protected with heterologous bone marrow when the cells are injected at 24 hours after irradiation. On the basis of the number of cells required to produce a certain percentage of mortality, homologous lymph- node cells are somewhat more effective than homologous spleen cells, but much more eftective than homologous thymus cells. Mice that died 10 to 20 days or later after injection of homologous or heterologous lymphoid cells had symptoms and lesions which resembled those seen in mice that died from the secondary disease after foreign bone marrow transplantation. A pathological syndrome resembling the secondary disease has been evoked in a certain number of nonirradiated F/sub 1/ hybrid mice by the injection of a large number of lymphoid cells from parentalmore » strain mice that had been sensitized against isoantigens of the other parental strain. These observations support the concept of a graft- antihost reaction that is involved in the development of secondary disease. (auth)« less

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.